Results 21 to 30 of about 67,237 (216)
Case report: Misdiagnosis of primary mucinous cystadenoma of the testicle by ultrasound
Frontiers in Oncology, 2023 Testicular mucinous cystadenoma is a rare benign testicular tumor with the characteristics of being potentially malignant and showing atypical clinical symptoms; this article reports a case of a primary testicular mucinous cystadenoma misdiagnosed as ...
Linlin Zhang +9 more
doaj +1 more source
Cystic Primary Hepatic Neuroendocrine Tumor
The Korean Journal of Gastroenterology, 2021 Neuroendocrine tumors (NETs) can arise throughout the body. Most NETs in the liver are metastatic tumors; primary hepatic NET (PHNET) is extremely rare. A diagnosis of PHNET is very difficult.
Jin Mo Kim +4 more
doaj +1 more source
Episodic Biliary Obstruction: Intrahepatic Biliary Cystadenoma
Archives of Clinical and Experimental Surgery, 2014 Biliary cystadenomas are rare, benign but potentially malignant, multilocular, cystic neoplasms of a biliary origin. They often present with non-specific symptoms.
Ashwin Rammohan +2 more
doaj +1 more source
Pseudomyxoma Peritonei in a Patient with History of Breast Cancer
The Korean Journal of Gastroenterology, 2016 Pseudomyxoma peritonei is a very rare condition, and even rarer in patients with history of cancer. A 70-year old woman with a history of breast cancer was admitted with abdominal pain and distention.
Tae Seob Jung +6 more
doaj +1 more source
A Novel Case of Recurrent Mucinous Borderline Ovarian Tumor: Early Relapse and Fatal Outcome
Reports, 2022 Unlike ovarian carcinomas, borderline ovarian tumors (BOTs) are associated with a favorable prognosis: their recurrence rate is around 5–7%, and the survival rate is more than 97% when diagnosed early. There are only a few reports of recurrence and fatal
Kyoko Nakagawa +7 more
doaj +1 more source
Analysis of TP53 Codon 72 Polymorphism in Mucinous and Non-Mucinous Colorectal Adenocarcinoma in Isfahan, Iran [PDF]
Iranian Journal of Medical Sciences, 2010 Background: The tumor suppressor gene TP53 (alias p53)located on chromosome 17 is involved in various cancers.Case-control studies have shown that p53 codon 72 polymorphismmodulates the prognosis and susceptibility to variousmalignancies.
Mehdi Nikbahkt Dastjerdi
doaj
Indian Journal of Pathology and Microbiology, 2018 Borderline mucinous tumor (BMT) is often associated with other entities such as dermoid cyst, Brenner tumor, and endometriosis. Squamous areas are often associated which may be a part of BMT or its associated conditions.
Geetha Vasudevan +3 more
doaj +1 more source
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source
Molecular Oncology, EarlyView.Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Molecular Oncology, EarlyView.LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David +12 more
wiley +1 more source